1-4 of 4
Marti McKinley
Close
Sort by
Journal Articles

A Phase II Study of Bortezomib (Velcade ® ), Cyclophosphamide (Cytoxan ® ), Thalidomide (Thalomid ® ) and Dexamethasone as First-Line Therapy for Multiple Myeloma

William Bensinger, Sundar Jagannath, MD, Robert Vescio, MD, Elber S. Camacho, MD, Jeffrey Lee Wolf, David H Irwin, MD, Gerardo Capo, III, MD, Marti McKinley, Phyllis Potts, David H. Vesole, MD, PhD, Amitabha Mazumder, MD, Dixie-Lee Esseltine, MD, Pamela Becker, John Crowley, PhD, Brian GM Durie, MD
Journal: Blood
Blood (2008) 112 (11): 94.
https://doi.org/10.1182/blood.V112.11.94.94
Published: 2008
Journal Articles

A Phase II Study of Bortezomib (Velcade®), Cylophosphamide (Cytoxan®), Thalidomide (Thalomid ®) and Dexamethasone as First-Line Therapy for Multiple Myeloma.

Sundar Jagannath, MD, Bill Bensinger, MD, Robert Vescio, MD, Elber Camacho, MD, Jeffrey Wolf, MD, David Irwin, MD, Gerardo Capo, MD, Marti McKinley, MD, David H. Vesole, MD, Amitabha Mazumder, MD, John Crowley, MD, Dixie Esseltine, MD, Brian Durie, MD
Journal: Blood
Blood (2007) 110 (11): 188.
https://doi.org/10.1182/blood.V110.11.188.188
Published: 2007
Journal Articles

Long-Term Follow-Up of Patients Treated with Bortezomib Alone and in Combination with Dexamethasone as Frontline Therapy for Multiple Myeloma.

Sundar Jagannath, MD, Brian G.M. Durie, MD, Jeffrey Lee Wolf, MD, Elber S. Camacho, David Irwin, MD, Jose Lutzky, MD, Marti McKinley, BSN, Afshin Eli Gabayan, MD, Amitabha Mazumder, MD, John Crowley, PhD, Robert Vescio, MD
Journal: Blood
Blood (2006) 108 (11): 796.
https://doi.org/10.1182/blood.V108.11.796.796
Published: 2006
Journal Articles

A Phase 2 Study of Bortezomib as First-Line Therapy in Patients with Multiple Myeloma.

Sundar Jagannath, MD, Durie Brian, MD, Jeffrey L. Wolf, MD, Elber Camacho, MD, David Irwin, MD, Jose Lutzky, MD, Marti McKinley, MD, Eli Gabayan, MD, Amitabha Mazumder, MD, John Crowley, PhD, David Schenkein, MD
Journal: Blood
Blood (2004) 104 (11): 333.
https://doi.org/10.1182/blood.V104.11.333.333
Published: 2004